Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Coloplast A/S    COLO B   DK0060448595

Delayed Quote. Delayed  - 09/20 09:24:04 am
497.8 DKK   -0.32%
09/12 COLOPLAST A/S : Insider tradings
08/24 COLOPLAST A/S : Announcement no. 6/2017 - Financial calendar 2017/18
08/18 COLOPLAST A/S : delivers satisfactory Q3 result
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Coloplast A/S : Patent Issued for Method of Providing a Patient with an Implanted Penile Prosthetic Adapted to Provide Improved Flow of Blood to a Glans Penis (USPTO...

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/14/2017 | 10:32pm CEST

Patent Issued for Method of Providing a Patient with an Implanted Penile Prosthetic Adapted to Provide Improved Flow of Blood to a Glans Penis (USPTO 9750609)

By a News Reporter-Staff News Editor at Journal of Engineering -- Coloplast A/S (Humlebaek, DK) has been issued patent number 9750609, according to news reporting originating out of Alexandria, Virginia, by VerticalNews editors.

The patent's inventor is Taylor, Jeffrey Brian (Forest Lake, MN).

This patent was filed on October 18, 2016 and was published online on September 5, 2017.

From the background information supplied by the inventors, news correspondents obtained the following quote: "An implanted penile prosthetic is effective in relieving erectile dysfunction in men.

"A penile prosthetic typically includes a cylinder that is implanted in each corpora cavernosum of the penis as well as a fluid reservoir and pump and valve mechanisms to move fluid from the reservoir to the cylinder to create an erection in the penis. Other penile prosthetics include a malleable cylinder without inflation fluid. The erectile dysfunction condition is typically a result of reduced or no blood supply to the tissue of the corpora cavernosum leading to the sponge-like tissue of the corpora losing its expanding capability. The lack of blood supply to the corpora cavernosa may be caused by both psychological and physiological reasons and/or as a reaction to medication.

"Placement of a cylinder in the corpora cavernosum in a surgical procedure includes dilating the sponge-like tissue of the corpora cavernosum with a Brooks.RTM. corporal dilator to form an implant space sized to receive the cylinder.

"The above-described penile prosthetics have proven effective in relieving erectile dysfunction in men. However, improvements to penile prostheses would be welcomed by surgeons and patients alike."

Supplementing the background information on this patent, VerticalNews reporters also obtained the inventor's summary information for this patent: "One aspect provides an implantable penile prosthetic insert that is configured to be placed in a corpora cavernosum of a penis and to transition the penis between a flaccid and an erect state. The insert includes a body formed of a bio-compatible material and extends between a proximal end and a distal end. The body includes an exterior surface defining a channel extending longitudinally along at least part of the body. The body is configured to transition between a first state corresponding to the flaccid state of the penis and a second state corresponding to the erect state of the penis. The channel is more resistant to deformation than a surrounding portion of the body such that the channel is present in both the first and the second state.

"One aspect provides an implantable penile prosthetic insert that is configured to be placed in a corpora cavernosum of a penis and to transition the penis between a flaccid and an erect state. The insert includes a body formed of a bio-compatible material and extends between a proximal end and a distal end. The body includes an exterior surface defining a channel extending longitudinally along at least part of the body. The body is configured to transition between a first state corresponding to the flaccid state of the penis and a second state corresponding to the erect state of the penis. The channel is present in both the first and the second state.

"One aspect provides a penile prosthetic system including an inflatable cylinder, a reservoir for storing of liquid and a pump connected between the reservoir and the chamber via tubing. The inflatable cylinder includes a body formed of a bio-compatible material extending between a proximal end and a distal end and having an exterior surface defining a channel extending longitudinally along at least part of the body. The channel is more resistant to deformation than a surrounding portion of the body such that the channel is present in both a deflated state and an inflated state of the body.

"One aspect provides a method of implanting a penile prosthetic insert in a patient. The method includes making an incision in a patient and minimally dilating the corpora cavernosum to keep as much healthy tissue as possible in the corpora cavernosum. The method further includes introducing an insert comprising a body formed of a bio-compatible material and extending between a proximal end and a distal end and having an exterior surface defining a channel extending longitudinally along at least part of the body. The method further includes adjusting the position of the insert in the corpora cavernosum.

"One aspect provide a kit of parts including a packaging, an insert positioning tool, a set of instructions for use and an implantable penile prosthetic insert configured to be placed in a corpora cavernosum of a penis and to transition the penis between a flaccid and an erect state. The body includes a bio-compatible material extending between a proximal end and a distal end and having an exterior surface defining a channel extending longitudinally along at least part of the body. The channel is present in both the first and the second state and sized to accommodate at least a portion of the insert positioning tool."

For the URL and additional information on this patent, see: Taylor, Jeffrey Brian. Method of Providing a Patient with an Implanted Penile Prosthetic Adapted to Provide Improved Flow of Blood to a Glans Penis. U.S. Patent Number 9750609, filed October 18, 2016, and published online on September 5, 2017. Patent URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9750609.PN.&OS=PN/9750609RS=PN/9750609

Keywords for this news article include: Impotence, Men's Health, Coloplast A/S, Erectile Dysfunction, Male Genital Diseases and Conditions.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

(c) 2017 NewsRx LLC, source Science Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on COLOPLAST A/S
09/14 COLOPLAST A/S : Patent Issued for Method of Providing a Patient with an Implante..
09/14 COLOPLAST A/S : Patent Issued for Surgical System for and a Method of Identifyin..
09/12 COLOPLAST A/S : Insider tradings
09/07 COLOPLAST A/S : Patent Issued for Method of Treating Prolapse of a Vagina by Pro..
09/07 COLOPLAST A/S : Patent Issued for Incontinence Treatment Device (USPTO 9744016)
08/24 COLOPLAST A/S : Announcement no. 6/2017 - Financial calendar 2017/18
08/18 COLOPLAST A/S : delivers satisfactory Q3 result
08/18 COLOPLAST A/S : Announcement no. 5/2017 - Meet the Management Event
08/17 COLOPLAST A/S : Patent Issued for Tool with a Suction Feature Useful for Implant..
08/16 COLOPLAST A/S : delivers satisfactory Q3 result
More news
News from SeekingAlpha
08/21 Coloplast (CLPBY) Investor Presentations - Slideshow
08/17 Coloplast's (CLPBF) CEO Lars Rasmussen on Q3 2017 Results - Earnings Call Tra..
08/16 Coloplast AS ADR 2017 Q3 - Results - Earnings Call Slides
08/16 Coloplast ASB reports Q3 results
05/03 Coloplast's (CLPBF) CEO Lars Rasmussen on Q2 2017 Results - Earnings Call Tra..
Financials ( DKK)
Sales 2017 15 607 M
EBIT 2017 5 069 M
Net income 2017 3 819 M
Debt 2017 1 182 M
Yield 2017 2,75%
P/E ratio 2017 27,47
P/E ratio 2018 24,84
EV / Sales 2017 6,41x
EV / Sales 2018 5,98x
Capitalization 98 881 M
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | COLO B | DK0060448595 | 4-Traders
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 545  DKK
Spread / Average Target 9,1%
EPS Revisions
Managers
NameTitle
Lars Søren Rasmussen President & Chief Executive Officer
Michael Pram Rasmussen Chairman
Allan Rasmussen Executive Vice President-Global Operations
Anders Lonning-Skovgaard CFO, Executive VP & Head-Investor Relations
Oliver Johansen Senior VP-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
COLOPLAST A/S5.29%15 965
HENRY SCHEIN9.26%12 513
CANTEL MEDICAL CORP.8.15%3 655
PATTERSON COMPANIES, INC.-6.09%3 558
AMPLIFON SPA41.33%3 458
MERIT MEDICAL SYSTEMS, INC.56.60%2 058